文獻標題及相關內容： 1. In vitro and in vivo metabolism of rimonabant (SR-141716), a cannabinoid (CB1) receptor antagonist 2. 各種動物およびヒトにおける LFP83 の體內動態 3. LFP83靜脈內投與によるラット分布, 代謝および排泄 4. 34 - Disorders of Blood Cell Production in Clinical Oncology 5. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy   [更多]

文獻標題及相關內容： 1.Ohmukai O.Lipo- NSAID preparation[J].Adv Drug Deliv Rev 2.Less pain on injection by a new formulation of propofol? A comparison with propofol LCT 3.Tohno, M.，Konishi , Y.，Kojima , H., Kawahara, K. and Horiba, M. (1992 ) Pharmacokinetics and metabolic studies of LFP83 in man after the single and repeated intravenous administration. Clin. Rep. 26, 3907-3921. 4.Naito, Y. et al.：Arzneim.-Forsch.Drug Res., 46(II), 698-700, 1996 5.What is the Role of NSAIDs in Pre-emptive Analgesia?   [更多]

1.Bulletin of the Chemical Society of Japan, Volume 26, Pages 119-122, Journal, 1953 2.Dalton Transactions 2017,vol. 46, # 5, p. 1510 - 1519 3.Design and evaluation of ophthalmic pharmaceutical products. In Banker GS, Rhodes CT, eds. Modern Pharmaceutics, 4th edn. New York Marcel Dekker, 2002 415-478 4.Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer 5.Journal of Photochemistry and Photobiology, B Biology, Volume 97, Issue 1, Pages 18-21, Journal, 2009 6.Journal of Photochemistry and Photobiology, B Biology, Volume 115, Pages 51-57, Journal; Online Computer File, 2012 7.Nair AD, Lach JL. The kinetics of degradation of chlorobutanol. J Am Pharm Assoc (Sci) 1959; 48 390-395. 8.Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine 9.Plasma?renin?activity-guided strategy for the management of hypertension. 10.Stability of chlorobutanol in aqueous solutions Journal of the American Pharmaceutical Association (1961), Volume 6, Issue 7, July 1966, Pages 372-373 11.Talanta, Volume 146, Pages 732-736, Journal; Online Computer File, 2016   [更多]

1. Miller J. Ogidigben, Teh-Ching Chu and David E. Potter. Naphazoline-induced neuroendocrine changes Increases in ANP and cGMP levels 2. Robert J. Dockhorn and Thomas G. Duckett. Comparison of Naphcon-A and Its components 3. Mark B, Abelson MD, Salim I, et al. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage 4. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flowinvolvement of central and peripheral alpha(2) I(1) receptors 5. The efficacy of long-term treatment with Tolvaptan to prolong the time until dialysis initiation in patients with chronic kidney disease and heart failure 6. Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion 7. Tolvaptan Efficiently Reduces Intracellular Fluid Working Toward a Potential Treatment Option for Cellular Edema 8. Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites 9. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease 10. Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement 11. Nephrol Dial Transplant. 2018 Oct 12. doi 10.1093ndtgfy297. [Epub ahead of print] 12. Nephrol Dial Transplant. 2018 Oct 11. doi 10.1093ndtgfy298. [Epub ahead of print] 13. Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form 14. Stability-indicating methods for the determination of Ornidazole in the presence of its degradate according to ICH guidelines 15. A sensitive HPLC method of determination of 2-methyl 5-nitro imidazole & reaction mass of intermediates of ornidazole in ornidazole bulk manufacturing 16. Development and validation of a reversed-phase HPLC method for the analysis of ornidazole in pharmaceutical dosage forms 17. On the hydrolytic behavior of tinidazole, metronidazole,   [更多]

1、Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), Volume: 9, Pages: 957-64(in English 964), Journal, 1936. 2、Chemicke Listy pro Vedu a Prumysl, Volume: 37, Pages: 289-90, Journal, 1943. 3、Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer. 4. Drugs Today (Barc). 2018 Sep;54(9):519-533. doi: 10.1358/dot.2018.54.9.2776624. An update on tolvaptan for autosomal dominant polycystic kidney disease. Poch E1, Rodas L2, Blasco M2, Molina A2, Quintana L2. 5.Parameter optimization and process control for the sterilization of ornidazole and sodium chloride injection 6.Physical and pharmacotechnological studies of ornidazole drug 7. Analytical studies for the determination of ornidazole in the presence of degradation products By Visan, Veronica; Ionescu, Mariana S.; Dragos, Mariana; Belu, Dan; Cosofret, Vasile From Revistade Chimie (Bucharest, Romania) (1989), 40(8), 728-31. Language: Romanian, Database: CAPLUS 8. Reactions of nitroimidazoles with free radicals--enhancement of reaction by u.v. irradiation By Moore D E From International journal of radiation biology and related studies in physics, chemistry, and medicine (1985), 47(5),563-8, Language: English, Database: MEDLINE   [更多]

求DOF期刊2018年10-12期文獻   [更多]

一共5篇，可以只投稿其中的幾篇，也是可以的。 第一篇： 20 De Carli G, Irvine SH, Arpinelli F, Bamfi F, Olivieri A, Recchia G. [Development and validation of QPD 32, a specific questionnaire for measuring the quality of life of patients with peptic ulcer.] Minerva Gastroenterol. Dietol. 1995; 41: 275–82 (in Italian). 第二篇：FDA Drug Bull 1986,16(1):3. 第三篇：Boucher DW, Furesz J, Regulatory control of blood products. Canada Dev elop Bi- 05 Stantard, 1987, 67: 221 第四篇： Clinical trial of phloroglucinol-trimethyl ether in the treatment of biliary and intestinal diseases 第五篇：Effect of phloroglucinol on rectosigmoid motility stimulated by a test meal. Study in patients with irritable bowel syndrome   [更多]

1.Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination 2.Review of activity and therapeutic use of sulbactam with ampicillin: D. M. Campoli-Richards, R. N. Brogden, Drugs 33, 577-609 (1987). 3.中藥大品種科技競爭力報告 2018版 4.Comparisons of synthetic 1-18 ACTH (Organon 2001) and 1-39 ACTH of animal origin in human subjects. Behav Neuropsychiatry. 1976 Apr-1977 Mar;8(1-12):3-5. 5. Chem.Abstr.1961# 24578 6. Doklady TSKhA1960vol. 52p. 443,444-450 7. 4.Perez-Ruiz F, Hingorani V, Welp J, et al. Efficacy and safety of a range of doses of RDEA594, a novel uricosuric agent, as a single agent in hyperuricemic gout patients: multicenter, randomized, double-blind, placebo-controlled, phase 2 experience [J]. Ann Rheum Dis, 2010, 69(Suppl 3): 121 8. 化學療法の領域（） 名稱：Stability of cefoperazone By: Takakura, Isamu; Kokei, Tetsuo; Watanabe, Keiko Source: Kagaku Ryoho no Ryoiki（化學療法の領域）, Volume: 6, Issue: 2, Pages: 324-34, Journal, 1990, CODEN: KRRYEI, ISSN: 0913-2384 Company/Organization: Toyama Kagaku Kogyo K. K., Japan   [更多]

公司需求幾篇藥品文獻資料。臨床應用數據。具體產品私信我找到一篇50元   [更多]

1.Nihon Yakurigaku Zasshi. 2013 Jul;142(1):39-46. doi: 10.1254/fpj.142.39. Pharmacological and clinical properties of AIMIX combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate. 2.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 3.Clin Ther. 2012 Aug;34(8):1705-19. doi: 10.1016/j.clinthera.2012.06.026. Epub 2012 Jul 30. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 4.Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 5.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 6J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053-X. doi: 10.1016/j.jjcc.2019.03.001. [Epub ahead of print] Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR1. 7.Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability 8.Expert Rev Neurother. 2017 Jan;17(1):59-75. Epub 2016 Oct 20. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Tramutola A1, Arena A1,   [更多]